Under construction – not a live service
Sign in
Taking people in GermanyNo phase

Follows people with eczema or psoriasis skin disease over time through samples

Collects blood and skin samples from people with eczema, psoriasis or no skin disease.

Plain-language title generated from the registry record
Registry title: Disease Trajectories and Anti-cytokine Response Signatures in Atopic Dermatitis and Psoriasis

Key facts

Where
Kiel, GermanySee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 0 and 100 years old?

Source: NCT03361215, who can take part

Where in Germany

  • Department of Dermatology, University Hospital Schleswig Holstein, Campus KielKiel, GermanyTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University Hospital Schleswig-Holstein
Trial code
NCT03361215
Record updated
22 July 2025
Original description
The clinical study investigates the long-term course of disease in patients with chronic inflammatory skin diseases (atopic eczema and psoriasis) and the impact of tarheted therapies on the clinical and molecular level. For this purpose, patients are asked to take part in regular examinations and data collections, and to donate biomaterials (blood, skin biopsies, skin swabs, tape strips, stool samples). Blood samples are used to analyze inflammation messengers. Punch biopsies from lesional and non-lesional skin areas are used to analyze gene expression. Tape strips are pieces of transparent adhesive tapes to strip off most of the horny layer that will be used to examine mRNA and protein expression. The skin smears are superficial smears of three areas of skin with cotton swabs, which are used to examine bacteria on the skin. Overall, the study will help to monitor the disease course clinically and on the molecular level in participating patients for at least ten years and to collect information about the impact of various external factors including treatments. The study has no effect on the therapies of the disease, it serves only the accompanying data collectionRead full original descriptionShow less

Disease Trajectories in Atopic Dermatitis and Psoriasis

The clinical study investigates the long-term course of disease in patients with chronic inflammatory skin diseases (atopic eczema and psoriasis) and the impact of tarheted therapies on the clinical and molecular level. For this purpose, patients are asked to take part in regular examinations and data collections, and to donate biomaterials (blood, skin biopsies, skin swabs, tape strips, stool samples). Blood samples are used to analyze inflammation messengers. Punch biopsies from lesional and non-lesional skin areas are used to analyze gene expression. Tape strips are pieces of transparent adhesive tapes to strip off most of the horny layer that will be used to examine mRNA and protein expression. The skin smears are superficial smears of three areas of skin with cotton swabs, which are used to examine bacteria on the skin. Overall, the study will help to monitor the disease course clinically and on the molecular level in participating patients for at least ten years and to collect information about the impact of various external factors including treatments. The study has no effect on the therapies of the disease, it serves only the accompanying data collection

Inclusion: Patients with a clinical diagnosis of atopic dermatitis, psoriasis or autoimmune skin disease; Written informed consent obtained from the subject.

Exclusion: Patients who decline participation; In patients<18 years of age no biopsies will be taken.

ClinicalTrials.gov NCT03361215